196 related articles for article (PubMed ID: 34362504)
1. [Two Serum Free Light Chain Detection Systems in the Diagnosis of Multiple Myeloma].
Zhu GQ; Fu X; Ren YS; Wang YS; Wang SL; Wang LC; Lin J; An G
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1209-1215. PubMed ID: 34362504
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of three serum-free light-chain detection systems in the diagnosis of multiple myeloma.
Zhu G; Fu X; Ren Y; Wang Y; Wang S; An G
Int J Lab Hematol; 2022 Jun; 44(3):576-581. PubMed ID: 35060324
[TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of serum free light chains measurement in patients with multiple myeloma: comparative analysis of two different tests.
Kubicki T; Dytfeld D; Baszczuk A; Wysocka E; Komarnicki M; Lewandowski K
Postepy Hig Med Dosw (Online); 2017 Jan; 71(0):40-46. PubMed ID: 28181910
[TBL] [Abstract][Full Text] [Related]
4. Clinical implication by differential analytical performances of serum free light chain quantitation analysis using fully automated analyzers.
Yun SY; Rim JH; Park H; Kang H; Lee SG; Lim JB
Clin Chem Lab Med; 2023 Jun; 61(7):1288-1299. PubMed ID: 37015073
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Freelite and N-Latex serum free light chain assays: a critical review.
Daves M; Piccin A; Roccaforte V; Lippi G
Biochem Med (Zagreb); 2021 Oct; 31(3):030701. PubMed ID: 34393594
[TBL] [Abstract][Full Text] [Related]
6. Effects of Long-Term Storage on Serum Free Light Chain Stability.
Hörber S; Klein R; Peter A
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115238
[TBL] [Abstract][Full Text] [Related]
7. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis.
Hoedemakers RM; Pruijt JF; Hol S; Teunissen E; Martens H; Stam P; Melsert R; Te Velthuis H
Clin Chem Lab Med; 2011 Nov; 50(3):489-95. PubMed ID: 22098433
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay.
Sasson SC; McGill K; Wienholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA
Pathology; 2015 Oct; 47(6):564-9. PubMed ID: 26352111
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of determination of free light chains (Kappa and Lambda) in plasma and serum by Swedish laboratories as monitored by external quality assessment.
Rollborn N; Jakobsson J; Campbell A; Nordin G; Karlsson M; Larsson A; Kultima K
Clin Biochem; 2023 Jan; 111():47-53. PubMed ID: 36241061
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients.
Henriot B; Rouger E; Rousseau C; Escoffre M; Sébillot M; Bendavid C; Minvielle S; Avet-Loiseau H; Decaux O; Moreau C
Clin Chem Lab Med; 2019 Aug; 57(9):1397-1405. PubMed ID: 30973821
[TBL] [Abstract][Full Text] [Related]
11. FLC polymerization: Another hurdle towards standardization of FLC measurements.
Kaplan B; Jacobs JFM
Clin Chim Acta; 2021 Apr; 515():42-43. PubMed ID: 33388308
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the N-latex serum free light chain assay on the Siemens BNII analyzer and agreement with The Binding Site FreeLite assay on the SPA
White-Al Habeeb NMA; Earle T; Spencer M; Blasutig IM
Clin Biochem; 2018 Jan; 51():90-96. PubMed ID: 28512013
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis.
Kennard A; Hawley C; Tate J; Klingberg S; Pretorius C; Hutchison C; Mollee P
Clin Chem Lab Med; 2016 Jun; 54(6):1045-52. PubMed ID: 26684350
[TBL] [Abstract][Full Text] [Related]
14. Performance Evaluation of Serum Free Light Chain Analysis: Nephelometry vs Turbidimetry, Monoclonal vs Polyclonal Reagents.
Messiaen AS; De Sloovere MMW; Claus PE; Vercammen M; Van Hoovels L; Heylen O; Debrabandere J; Vanpoucke H; De Smet D
Am J Clin Pathol; 2017 Jun; 147(6):611-622. PubMed ID: 28575180
[TBL] [Abstract][Full Text] [Related]
15. Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free κ to λ light chains.
Xu Y; Sui W; Deng S; An G; Wang Y; Xie Z; Yao H; Zhu G; Zou D; Qi J; Hao M; Zhao Y; Wang J; Chen T; Qiu L
Leuk Lymphoma; 2013 Jan; 54(1):123-32. PubMed ID: 22712834
[TBL] [Abstract][Full Text] [Related]
16. Inter-assay variability in automated serum free light chain assays and their use in the clinical laboratory.
Caponi L; Romiti N; Koni E; Fiore AD; Paolicchi A; Franzini M
Crit Rev Clin Lab Sci; 2020 Mar; 57(2):73-85. PubMed ID: 31612753
[TBL] [Abstract][Full Text] [Related]
17. Method comparison of three serum free light chain assays on the Roche Cobas 6000 c501 chemistry analyzer.
Augustijn D; Jacobs JFM; Russcher H
Clin Chem Lab Med; 2022 Feb; 60(3):379-385. PubMed ID: 34969184
[TBL] [Abstract][Full Text] [Related]
18. Clinical comparisons of two free light chain assays to immunofixation electrophoresis for detecting monoclonal gammopathy.
Kim HS; Kim HS; Shin KS; Song W; Kim HJ; Kim HS; Park MJ
Biomed Res Int; 2014; 2014():647238. PubMed ID: 24971342
[TBL] [Abstract][Full Text] [Related]
19. N Latex FLC serum free light-chain assays in patients with renal impairment.
Jacobs JF; Hoedemakers RM; Teunissen E; Te Velthuis H
Clin Chem Lab Med; 2014 Jun; 52(6):853-9. PubMed ID: 24406282
[TBL] [Abstract][Full Text] [Related]
20. Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio.
Rindlisbacher B; Schild C; Egger F; Bacher VU; Pabst T; Leichtle A; Andres M; Sédille-Mostafaie N
J Appl Lab Med; 2020 Jan; 5(1):114-125. PubMed ID: 32445339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
